Pedro Horna

2.3k total citations
73 papers, 1.5k citations indexed

About

Pedro Horna is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Pedro Horna has authored 73 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 26 papers in Pathology and Forensic Medicine and 23 papers in Oncology. Recurrent topics in Pedro Horna's work include Lymphoma Diagnosis and Treatment (26 papers), Cutaneous lymphoproliferative disorders research (20 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Pedro Horna is often cited by papers focused on Lymphoma Diagnosis and Treatment (26 papers), Cutaneous lymphoproliferative disorders research (20 papers) and Chronic Lymphocytic Leukemia Research (14 papers). Pedro Horna collaborates with scholars based in United States, United Kingdom and Spain. Pedro Horna's co-authors include Eduardo M. Sotomayor, Horatiu Olteanu, Lubomir Sokol, Min Shi, Dragan Jevremović, Fengdong Cheng, Alejandro Villagra, Alex G. Cuenca, Gregory E. Otteson and Judith C. McCaffrey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Pedro Horna

68 papers receiving 1.4k citations

Peers

Pedro Horna
Karen P. Mann United States
W Vos Netherlands
Alexandra C. Hristov United States
A.C. Feller Germany
Pedro Horna
Citations per year, relative to Pedro Horna Pedro Horna (= 1×) peers Ingrid Simonitsch

Countries citing papers authored by Pedro Horna

Since Specialization
Citations

This map shows the geographic impact of Pedro Horna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Horna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Horna more than expected).

Fields of papers citing papers by Pedro Horna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Horna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Horna. The network helps show where Pedro Horna may publish in the future.

Co-authorship network of co-authors of Pedro Horna

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Horna. A scholar is included among the top collaborators of Pedro Horna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Horna. Pedro Horna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Oak, Jean, Pedro Horna, Jonathan R. Fromm, et al.. (2025). A practical approach to panel design, validation, and interpretation for the evaluation of T ‐cell neoplasms by flow cytometry. Cytometry Part B Clinical Cytometry. 108(6). 430–447.
4.
Seheult, Jansen N., et al.. (2024). Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features. Journal of Investigative Dermatology. 144(7). 1590–1599.e3. 3 indexed citations
5.
Horna, Pedro, Mathieu Ferrari, Gregory E. Otteson, et al.. (2024). Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry. Blood Cancer Journal. 14(1). 34–34. 13 indexed citations
6.
Lahr, Brian D., Carrie M. Carr, Felix E. Diehn, et al.. (2023). 1287. Assessing the Utility of Vertebral Body / Disc Space Fluid Cell Differential in the Diagnosis of Native Vertebral Osteomyelitis. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
7.
Seheult, Jansen N., Gregory E. Otteson, Dragan Jevremović, et al.. (2023). Establishing NK-Cell Receptor Restriction by Flow Cytometry and Detecting Potential NK-Cell Clones of Uncertain Significance. Modern Pathology. 36(8). 100255–100255. 5 indexed citations
8.
Horna, Pedro, Rebecca L. King, Dragan Jevremović, David C. Fajgenbaum, & Angela Dispenzieri. (2022). The lymph node transcriptome of unicentric and idiopathic multicentric Castleman disease. Haematologica. 108(1). 207–218. 13 indexed citations
9.
Horna, Pedro, Min Shi, Dragan Jevremović, et al.. (2020). Utility of TRBC1 Expression in the Diagnosis of Peripheral Blood Involvement by Cutaneous T-Cell Lymphoma. Journal of Investigative Dermatology. 141(4). 821–829.e2. 26 indexed citations
10.
Shi, Min, Horatiu Olteanu, Dragan Jevremović, et al.. (2020). T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics. Modern Pathology. 33(10). 2046–2057. 52 indexed citations
11.
Vaughan, James, Min Shi, Pedro Horna, & Horatiu Olteanu. (2020). Increased CD200 expression in post-transplant lymphoproliferative disorders correlates with an increased frequency of FoxP3(+) regulatory T cells. Annals of Diagnostic Pathology. 48. 151585–151585. 4 indexed citations
12.
Horna, Pedro, et al.. (2020). New Insights Into the Complex Mutational Landscape of Sézary Syndrome. Frontiers in Oncology. 10. 514–514. 12 indexed citations
13.
Mirza, Abu‐Sayeef, Bhagirathbhai Dholaria, Mohammad Hussaini, et al.. (2019). High-dose Therapy and Autologous Hematopoietic Cell Transplantation as Consolidation Treatment for Primary Effusion Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 19(9). e513–e520. 3 indexed citations
14.
Shi, Min, Karen L. Rech, Gregory E. Otteson, et al.. (2019). Prevalence and spectrum of T-cell lymphoproliferative disorders in patients with Hypereosinophilia: A reference laboratory experience. Annals of Diagnostic Pathology. 44. 151412–151412. 8 indexed citations
15.
Horna, Pedro, Terra L. Lasho, Christy M. Finke, et al.. (2018). Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of thirty‐nine patients. American Journal of Hematology. 93(11). 1347–1357. 11 indexed citations
16.
Horna, Pedro, Lynn C. Moscinski, Lubomir Sokol, & Haipeng Shao. (2018). Naïve/memory T‐cell phenotypes in leukemic cutaneous T‐cell lymphoma: Putative cell of origin overlaps disease classification. Cytometry Part B Clinical Cytometry. 96(3). 234–241. 24 indexed citations
17.
Salem, Karma Z., Taiga Nishihori, Mohamed A. Kharfan‐Dabaja, Pedro Horna, & Melissa Alsina. (2015). Primary plasmacytoma involving mediastinal lymph nodes. Hematology/Oncology and Stem Cell Therapy. 9(1). 26–29. 4 indexed citations
18.
Cheng, Fengdong, Hongwei Wang, Pedro Horna, et al.. (2012). Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity. Cancer Research. 72(17). 4440–4448. 15 indexed citations
19.
Takahashi, Yoshinori, et al.. (2007). Identification of a novel negative role of flagellin in regulating IL‐10 production. European Journal of Immunology. 37(11). 3164–3175. 25 indexed citations
20.
Horna, Pedro & Eduardo M. Sotomayor. (2007). Cellular and Molecular Mechanisms of Tumor-Induced T-Cell Tolerance. Current Cancer Drug Targets. 7(1). 41–53. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026